AMWatch

Fonde skyder 320 millioner i dansk biotekselskab

Det 18 måneder gamle biotekselskab Snipr Biome har rejst 320 mio. kr. fra fire danske og udenlandske investorer, der skal hjælpe selskabet i dets forsøg på at finde penicillins afløser.

Christian Elling er som managing partner i Lundbeckfonden Emerge én af investorerne i det danske crispr-selskab Snipr Biome. | Photo: Lundbeckfonden

Lundbeckfonden har sammen med den hollandske LSP, tyske Wellington og danske North-East Family Office (Nefo) investeret 320 mio. kr. i den danske opstartvirksomhed Snipr Biome, der benytter sig af crispr-teknologien til at ramme bakterier.

Det skriver Dagbladet Børsen.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

The ESG market is controlled by a few big investors

Finland's largest investor holds 62 percent of shares of multi-trillion ETFs offered by iShares and 64 percent of Xtrackers' equivalent offering. Having a few investors dominating ownership in this way is not good for the vehicles' liquidity and could be a big challenge facing the sector.

"We continue to see further growth in our Nordic book of business"

DECEMBER SERIES: What were the most important developments at some of the global asset managers present on the Nordic market in 2021, and what are their expectations for the coming year? AMWatch's December series is kicked off by Head of Nordics at State Street Global Advisors, Arnaud Bruyneel. 

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch